Global Pet Meds and Supplements Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Pet Meds and Supplements Industry Forecast” looks at past sales and reviews total world Pet Meds and Supplements sales in 2022, providing a comprehensive analysis by region and market sector of projected Pet Meds and Supplements sales for 2023 through 2029. With Pet Meds and Supplements sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Meds and Supplements industry.
This Insight Report provides a comprehensive analysis of the global Pet Meds and Supplements landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Meds and Supplements portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pet Meds and Supplements market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Meds and Supplements and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Meds and Supplements.
The global Pet Meds and Supplements market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pet Meds and Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pet Meds and Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pet Meds and Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pet Meds and Supplements players cover Boehringer Ingelheim, Ceva Sante Animale, Bimeda Animal Health, Dechra Pharmaceuticals, Zoetis, Merck, Elanco, Bayer and Boehringer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Meds and Supplements market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Pet Meds and Supplements market?
What factors are driving Pet Meds and Supplements market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Meds and Supplements market opportunities vary by end market size?
How does Pet Meds and Supplements break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Pet Meds and Supplements Industry Forecast” looks at past sales and reviews total world Pet Meds and Supplements sales in 2022, providing a comprehensive analysis by region and market sector of projected Pet Meds and Supplements sales for 2023 through 2029. With Pet Meds and Supplements sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Meds and Supplements industry.
This Insight Report provides a comprehensive analysis of the global Pet Meds and Supplements landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Meds and Supplements portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pet Meds and Supplements market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Meds and Supplements and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Meds and Supplements.
The global Pet Meds and Supplements market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pet Meds and Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pet Meds and Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pet Meds and Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pet Meds and Supplements players cover Boehringer Ingelheim, Ceva Sante Animale, Bimeda Animal Health, Dechra Pharmaceuticals, Zoetis, Merck, Elanco, Bayer and Boehringer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Meds and Supplements market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- External Use
- Oral Use
- Dogs
- Cats
- Rabbit
- Bird
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim
- Ceva Sante Animale
- Bimeda Animal Health
- Dechra Pharmaceuticals
- Zoetis
- Merck
- Elanco
- Bayer
- Boehringer
- Novartis
- Virbac
- Ceva
- Vetoquinol
- Nexvet
- Aratana Therapeutics
- Kindred Biosciences
- Ambrx
- Entest Biomedical
- Taconic Biosciences
- Dechra Veterinary Products
- Ouro Fino Saude
- Norbrook
- Frontline
- Zesty Paws
What is the 10-year outlook for the global Pet Meds and Supplements market?
What factors are driving Pet Meds and Supplements market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Meds and Supplements market opportunities vary by end market size?
How does Pet Meds and Supplements break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet Meds and Supplements Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pet Meds and Supplements by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pet Meds and Supplements by Country/Region, 2018, 2022 & 2029
2.2 Pet Meds and Supplements Segment by Type
2.2.1 External Use
2.2.2 Oral Use
2.3 Pet Meds and Supplements Sales by Type
2.3.1 Global Pet Meds and Supplements Sales Market Share by Type (2018-2023)
2.3.2 Global Pet Meds and Supplements Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pet Meds and Supplements Sale Price by Type (2018-2023)
2.4 Pet Meds and Supplements Segment by Application
2.4.1 Dogs
2.4.2 Cats
2.4.3 Rabbit
2.4.4 Bird
2.4.5 Others
2.5 Pet Meds and Supplements Sales by Application
2.5.1 Global Pet Meds and Supplements Sale Market Share by Application (2018-2023)
2.5.2 Global Pet Meds and Supplements Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pet Meds and Supplements Sale Price by Application (2018-2023)
3 GLOBAL PET MEDS AND SUPPLEMENTS BY COMPANY
3.1 Global Pet Meds and Supplements Breakdown Data by Company
3.1.1 Global Pet Meds and Supplements Annual Sales by Company (2018-2023)
3.1.2 Global Pet Meds and Supplements Sales Market Share by Company (2018-2023)
3.2 Global Pet Meds and Supplements Annual Revenue by Company (2018-2023)
3.2.1 Global Pet Meds and Supplements Revenue by Company (2018-2023)
3.2.2 Global Pet Meds and Supplements Revenue Market Share by Company (2018-2023)
3.3 Global Pet Meds and Supplements Sale Price by Company
3.4 Key Manufacturers Pet Meds and Supplements Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Meds and Supplements Product Location Distribution
3.4.2 Players Pet Meds and Supplements Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PET MEDS AND SUPPLEMENTS BY GEOGRAPHIC REGION
4.1 World Historic Pet Meds and Supplements Market Size by Geographic Region (2018-2023)
4.1.1 Global Pet Meds and Supplements Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pet Meds and Supplements Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pet Meds and Supplements Market Size by Country/Region (2018-2023)
4.2.1 Global Pet Meds and Supplements Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pet Meds and Supplements Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pet Meds and Supplements Sales Growth
4.4 APAC Pet Meds and Supplements Sales Growth
4.5 Europe Pet Meds and Supplements Sales Growth
4.6 Middle East & Africa Pet Meds and Supplements Sales Growth
5 AMERICAS
5.1 Americas Pet Meds and Supplements Sales by Country
5.1.1 Americas Pet Meds and Supplements Sales by Country (2018-2023)
5.1.2 Americas Pet Meds and Supplements Revenue by Country (2018-2023)
5.2 Americas Pet Meds and Supplements Sales by Type
5.3 Americas Pet Meds and Supplements Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Meds and Supplements Sales by Region
6.1.1 APAC Pet Meds and Supplements Sales by Region (2018-2023)
6.1.2 APAC Pet Meds and Supplements Revenue by Region (2018-2023)
6.2 APAC Pet Meds and Supplements Sales by Type
6.3 APAC Pet Meds and Supplements Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet Meds and Supplements by Country
7.1.1 Europe Pet Meds and Supplements Sales by Country (2018-2023)
7.1.2 Europe Pet Meds and Supplements Revenue by Country (2018-2023)
7.2 Europe Pet Meds and Supplements Sales by Type
7.3 Europe Pet Meds and Supplements Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet Meds and Supplements by Country
8.1.1 Middle East & Africa Pet Meds and Supplements Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pet Meds and Supplements Revenue by Country (2018-2023)
8.2 Middle East & Africa Pet Meds and Supplements Sales by Type
8.3 Middle East & Africa Pet Meds and Supplements Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Meds and Supplements
10.3 Manufacturing Process Analysis of Pet Meds and Supplements
10.4 Industry Chain Structure of Pet Meds and Supplements
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Meds and Supplements Distributors
11.3 Pet Meds and Supplements Customer
12 WORLD FORECAST REVIEW FOR PET MEDS AND SUPPLEMENTS BY GEOGRAPHIC REGION
12.1 Global Pet Meds and Supplements Market Size Forecast by Region
12.1.1 Global Pet Meds and Supplements Forecast by Region (2024-2029)
12.1.2 Global Pet Meds and Supplements Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet Meds and Supplements Forecast by Type
12.7 Global Pet Meds and Supplements Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Pet Meds and Supplements Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Ceva Sante Animale
13.2.1 Ceva Sante Animale Company Information
13.2.2 Ceva Sante Animale Pet Meds and Supplements Product Portfolios and Specifications
13.2.3 Ceva Sante Animale Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Ceva Sante Animale Main Business Overview
13.2.5 Ceva Sante Animale Latest Developments
13.3 Bimeda Animal Health
13.3.1 Bimeda Animal Health Company Information
13.3.2 Bimeda Animal Health Pet Meds and Supplements Product Portfolios and Specifications
13.3.3 Bimeda Animal Health Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bimeda Animal Health Main Business Overview
13.3.5 Bimeda Animal Health Latest Developments
13.4 Dechra Pharmaceuticals
13.4.1 Dechra Pharmaceuticals Company Information
13.4.2 Dechra Pharmaceuticals Pet Meds and Supplements Product Portfolios and Specifications
13.4.3 Dechra Pharmaceuticals Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Dechra Pharmaceuticals Main Business Overview
13.4.5 Dechra Pharmaceuticals Latest Developments
13.5 Zoetis
13.5.1 Zoetis Company Information
13.5.2 Zoetis Pet Meds and Supplements Product Portfolios and Specifications
13.5.3 Zoetis Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Zoetis Main Business Overview
13.5.5 Zoetis Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Pet Meds and Supplements Product Portfolios and Specifications
13.6.3 Merck Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 Elanco
13.7.1 Elanco Company Information
13.7.2 Elanco Pet Meds and Supplements Product Portfolios and Specifications
13.7.3 Elanco Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Elanco Main Business Overview
13.7.5 Elanco Latest Developments
13.8 Bayer
13.8.1 Bayer Company Information
13.8.2 Bayer Pet Meds and Supplements Product Portfolios and Specifications
13.8.3 Bayer Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bayer Main Business Overview
13.8.5 Bayer Latest Developments
13.9 Boehringer
13.9.1 Boehringer Company Information
13.9.2 Boehringer Pet Meds and Supplements Product Portfolios and Specifications
13.9.3 Boehringer Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Boehringer Main Business Overview
13.9.5 Boehringer Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Pet Meds and Supplements Product Portfolios and Specifications
13.10.3 Novartis Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Virbac
13.11.1 Virbac Company Information
13.11.2 Virbac Pet Meds and Supplements Product Portfolios and Specifications
13.11.3 Virbac Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Virbac Main Business Overview
13.11.5 Virbac Latest Developments
13.12 Ceva
13.12.1 Ceva Company Information
13.12.2 Ceva Pet Meds and Supplements Product Portfolios and Specifications
13.12.3 Ceva Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Ceva Main Business Overview
13.12.5 Ceva Latest Developments
13.13 Vetoquinol
13.13.1 Vetoquinol Company Information
13.13.2 Vetoquinol Pet Meds and Supplements Product Portfolios and Specifications
13.13.3 Vetoquinol Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Vetoquinol Main Business Overview
13.13.5 Vetoquinol Latest Developments
13.14 Nexvet
13.14.1 Nexvet Company Information
13.14.2 Nexvet Pet Meds and Supplements Product Portfolios and Specifications
13.14.3 Nexvet Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Nexvet Main Business Overview
13.14.5 Nexvet Latest Developments
13.15 Aratana Therapeutics
13.15.1 Aratana Therapeutics Company Information
13.15.2 Aratana Therapeutics Pet Meds and Supplements Product Portfolios and Specifications
13.15.3 Aratana Therapeutics Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Aratana Therapeutics Main Business Overview
13.15.5 Aratana Therapeutics Latest Developments
13.16 Kindred Biosciences
13.16.1 Kindred Biosciences Company Information
13.16.2 Kindred Biosciences Pet Meds and Supplements Product Portfolios and Specifications
13.16.3 Kindred Biosciences Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Kindred Biosciences Main Business Overview
13.16.5 Kindred Biosciences Latest Developments
13.17 Ambrx
13.17.1 Ambrx Company Information
13.17.2 Ambrx Pet Meds and Supplements Product Portfolios and Specifications
13.17.3 Ambrx Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Ambrx Main Business Overview
13.17.5 Ambrx Latest Developments
13.18 Entest Biomedical
13.18.1 Entest Biomedical Company Information
13.18.2 Entest Biomedical Pet Meds and Supplements Product Portfolios and Specifications
13.18.3 Entest Biomedical Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Entest Biomedical Main Business Overview
13.18.5 Entest Biomedical Latest Developments
13.19 Taconic Biosciences
13.19.1 Taconic Biosciences Company Information
13.19.2 Taconic Biosciences Pet Meds and Supplements Product Portfolios and Specifications
13.19.3 Taconic Biosciences Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Taconic Biosciences Main Business Overview
13.19.5 Taconic Biosciences Latest Developments
13.20 Dechra Veterinary Products
13.20.1 Dechra Veterinary Products Company Information
13.20.2 Dechra Veterinary Products Pet Meds and Supplements Product Portfolios and Specifications
13.20.3 Dechra Veterinary Products Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Dechra Veterinary Products Main Business Overview
13.20.5 Dechra Veterinary Products Latest Developments
13.21 Ouro Fino Saude
13.21.1 Ouro Fino Saude Company Information
13.21.2 Ouro Fino Saude Pet Meds and Supplements Product Portfolios and Specifications
13.21.3 Ouro Fino Saude Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Ouro Fino Saude Main Business Overview
13.21.5 Ouro Fino Saude Latest Developments
13.22 Norbrook
13.22.1 Norbrook Company Information
13.22.2 Norbrook Pet Meds and Supplements Product Portfolios and Specifications
13.22.3 Norbrook Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Norbrook Main Business Overview
13.22.5 Norbrook Latest Developments
13.23 Frontline
13.23.1 Frontline Company Information
13.23.2 Frontline Pet Meds and Supplements Product Portfolios and Specifications
13.23.3 Frontline Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Frontline Main Business Overview
13.23.5 Frontline Latest Developments
13.24 Zesty Paws
13.24.1 Zesty Paws Company Information
13.24.2 Zesty Paws Pet Meds and Supplements Product Portfolios and Specifications
13.24.3 Zesty Paws Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Zesty Paws Main Business Overview
13.24.5 Zesty Paws Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet Meds and Supplements Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pet Meds and Supplements by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pet Meds and Supplements by Country/Region, 2018, 2022 & 2029
2.2 Pet Meds and Supplements Segment by Type
2.2.1 External Use
2.2.2 Oral Use
2.3 Pet Meds and Supplements Sales by Type
2.3.1 Global Pet Meds and Supplements Sales Market Share by Type (2018-2023)
2.3.2 Global Pet Meds and Supplements Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pet Meds and Supplements Sale Price by Type (2018-2023)
2.4 Pet Meds and Supplements Segment by Application
2.4.1 Dogs
2.4.2 Cats
2.4.3 Rabbit
2.4.4 Bird
2.4.5 Others
2.5 Pet Meds and Supplements Sales by Application
2.5.1 Global Pet Meds and Supplements Sale Market Share by Application (2018-2023)
2.5.2 Global Pet Meds and Supplements Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pet Meds and Supplements Sale Price by Application (2018-2023)
3 GLOBAL PET MEDS AND SUPPLEMENTS BY COMPANY
3.1 Global Pet Meds and Supplements Breakdown Data by Company
3.1.1 Global Pet Meds and Supplements Annual Sales by Company (2018-2023)
3.1.2 Global Pet Meds and Supplements Sales Market Share by Company (2018-2023)
3.2 Global Pet Meds and Supplements Annual Revenue by Company (2018-2023)
3.2.1 Global Pet Meds and Supplements Revenue by Company (2018-2023)
3.2.2 Global Pet Meds and Supplements Revenue Market Share by Company (2018-2023)
3.3 Global Pet Meds and Supplements Sale Price by Company
3.4 Key Manufacturers Pet Meds and Supplements Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Meds and Supplements Product Location Distribution
3.4.2 Players Pet Meds and Supplements Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PET MEDS AND SUPPLEMENTS BY GEOGRAPHIC REGION
4.1 World Historic Pet Meds and Supplements Market Size by Geographic Region (2018-2023)
4.1.1 Global Pet Meds and Supplements Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pet Meds and Supplements Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pet Meds and Supplements Market Size by Country/Region (2018-2023)
4.2.1 Global Pet Meds and Supplements Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pet Meds and Supplements Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pet Meds and Supplements Sales Growth
4.4 APAC Pet Meds and Supplements Sales Growth
4.5 Europe Pet Meds and Supplements Sales Growth
4.6 Middle East & Africa Pet Meds and Supplements Sales Growth
5 AMERICAS
5.1 Americas Pet Meds and Supplements Sales by Country
5.1.1 Americas Pet Meds and Supplements Sales by Country (2018-2023)
5.1.2 Americas Pet Meds and Supplements Revenue by Country (2018-2023)
5.2 Americas Pet Meds and Supplements Sales by Type
5.3 Americas Pet Meds and Supplements Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Meds and Supplements Sales by Region
6.1.1 APAC Pet Meds and Supplements Sales by Region (2018-2023)
6.1.2 APAC Pet Meds and Supplements Revenue by Region (2018-2023)
6.2 APAC Pet Meds and Supplements Sales by Type
6.3 APAC Pet Meds and Supplements Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet Meds and Supplements by Country
7.1.1 Europe Pet Meds and Supplements Sales by Country (2018-2023)
7.1.2 Europe Pet Meds and Supplements Revenue by Country (2018-2023)
7.2 Europe Pet Meds and Supplements Sales by Type
7.3 Europe Pet Meds and Supplements Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet Meds and Supplements by Country
8.1.1 Middle East & Africa Pet Meds and Supplements Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pet Meds and Supplements Revenue by Country (2018-2023)
8.2 Middle East & Africa Pet Meds and Supplements Sales by Type
8.3 Middle East & Africa Pet Meds and Supplements Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Meds and Supplements
10.3 Manufacturing Process Analysis of Pet Meds and Supplements
10.4 Industry Chain Structure of Pet Meds and Supplements
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Meds and Supplements Distributors
11.3 Pet Meds and Supplements Customer
12 WORLD FORECAST REVIEW FOR PET MEDS AND SUPPLEMENTS BY GEOGRAPHIC REGION
12.1 Global Pet Meds and Supplements Market Size Forecast by Region
12.1.1 Global Pet Meds and Supplements Forecast by Region (2024-2029)
12.1.2 Global Pet Meds and Supplements Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet Meds and Supplements Forecast by Type
12.7 Global Pet Meds and Supplements Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Pet Meds and Supplements Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Ceva Sante Animale
13.2.1 Ceva Sante Animale Company Information
13.2.2 Ceva Sante Animale Pet Meds and Supplements Product Portfolios and Specifications
13.2.3 Ceva Sante Animale Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Ceva Sante Animale Main Business Overview
13.2.5 Ceva Sante Animale Latest Developments
13.3 Bimeda Animal Health
13.3.1 Bimeda Animal Health Company Information
13.3.2 Bimeda Animal Health Pet Meds and Supplements Product Portfolios and Specifications
13.3.3 Bimeda Animal Health Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bimeda Animal Health Main Business Overview
13.3.5 Bimeda Animal Health Latest Developments
13.4 Dechra Pharmaceuticals
13.4.1 Dechra Pharmaceuticals Company Information
13.4.2 Dechra Pharmaceuticals Pet Meds and Supplements Product Portfolios and Specifications
13.4.3 Dechra Pharmaceuticals Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Dechra Pharmaceuticals Main Business Overview
13.4.5 Dechra Pharmaceuticals Latest Developments
13.5 Zoetis
13.5.1 Zoetis Company Information
13.5.2 Zoetis Pet Meds and Supplements Product Portfolios and Specifications
13.5.3 Zoetis Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Zoetis Main Business Overview
13.5.5 Zoetis Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Pet Meds and Supplements Product Portfolios and Specifications
13.6.3 Merck Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 Elanco
13.7.1 Elanco Company Information
13.7.2 Elanco Pet Meds and Supplements Product Portfolios and Specifications
13.7.3 Elanco Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Elanco Main Business Overview
13.7.5 Elanco Latest Developments
13.8 Bayer
13.8.1 Bayer Company Information
13.8.2 Bayer Pet Meds and Supplements Product Portfolios and Specifications
13.8.3 Bayer Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bayer Main Business Overview
13.8.5 Bayer Latest Developments
13.9 Boehringer
13.9.1 Boehringer Company Information
13.9.2 Boehringer Pet Meds and Supplements Product Portfolios and Specifications
13.9.3 Boehringer Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Boehringer Main Business Overview
13.9.5 Boehringer Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Pet Meds and Supplements Product Portfolios and Specifications
13.10.3 Novartis Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Virbac
13.11.1 Virbac Company Information
13.11.2 Virbac Pet Meds and Supplements Product Portfolios and Specifications
13.11.3 Virbac Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Virbac Main Business Overview
13.11.5 Virbac Latest Developments
13.12 Ceva
13.12.1 Ceva Company Information
13.12.2 Ceva Pet Meds and Supplements Product Portfolios and Specifications
13.12.3 Ceva Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Ceva Main Business Overview
13.12.5 Ceva Latest Developments
13.13 Vetoquinol
13.13.1 Vetoquinol Company Information
13.13.2 Vetoquinol Pet Meds and Supplements Product Portfolios and Specifications
13.13.3 Vetoquinol Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Vetoquinol Main Business Overview
13.13.5 Vetoquinol Latest Developments
13.14 Nexvet
13.14.1 Nexvet Company Information
13.14.2 Nexvet Pet Meds and Supplements Product Portfolios and Specifications
13.14.3 Nexvet Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Nexvet Main Business Overview
13.14.5 Nexvet Latest Developments
13.15 Aratana Therapeutics
13.15.1 Aratana Therapeutics Company Information
13.15.2 Aratana Therapeutics Pet Meds and Supplements Product Portfolios and Specifications
13.15.3 Aratana Therapeutics Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Aratana Therapeutics Main Business Overview
13.15.5 Aratana Therapeutics Latest Developments
13.16 Kindred Biosciences
13.16.1 Kindred Biosciences Company Information
13.16.2 Kindred Biosciences Pet Meds and Supplements Product Portfolios and Specifications
13.16.3 Kindred Biosciences Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Kindred Biosciences Main Business Overview
13.16.5 Kindred Biosciences Latest Developments
13.17 Ambrx
13.17.1 Ambrx Company Information
13.17.2 Ambrx Pet Meds and Supplements Product Portfolios and Specifications
13.17.3 Ambrx Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Ambrx Main Business Overview
13.17.5 Ambrx Latest Developments
13.18 Entest Biomedical
13.18.1 Entest Biomedical Company Information
13.18.2 Entest Biomedical Pet Meds and Supplements Product Portfolios and Specifications
13.18.3 Entest Biomedical Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Entest Biomedical Main Business Overview
13.18.5 Entest Biomedical Latest Developments
13.19 Taconic Biosciences
13.19.1 Taconic Biosciences Company Information
13.19.2 Taconic Biosciences Pet Meds and Supplements Product Portfolios and Specifications
13.19.3 Taconic Biosciences Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Taconic Biosciences Main Business Overview
13.19.5 Taconic Biosciences Latest Developments
13.20 Dechra Veterinary Products
13.20.1 Dechra Veterinary Products Company Information
13.20.2 Dechra Veterinary Products Pet Meds and Supplements Product Portfolios and Specifications
13.20.3 Dechra Veterinary Products Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Dechra Veterinary Products Main Business Overview
13.20.5 Dechra Veterinary Products Latest Developments
13.21 Ouro Fino Saude
13.21.1 Ouro Fino Saude Company Information
13.21.2 Ouro Fino Saude Pet Meds and Supplements Product Portfolios and Specifications
13.21.3 Ouro Fino Saude Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Ouro Fino Saude Main Business Overview
13.21.5 Ouro Fino Saude Latest Developments
13.22 Norbrook
13.22.1 Norbrook Company Information
13.22.2 Norbrook Pet Meds and Supplements Product Portfolios and Specifications
13.22.3 Norbrook Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Norbrook Main Business Overview
13.22.5 Norbrook Latest Developments
13.23 Frontline
13.23.1 Frontline Company Information
13.23.2 Frontline Pet Meds and Supplements Product Portfolios and Specifications
13.23.3 Frontline Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Frontline Main Business Overview
13.23.5 Frontline Latest Developments
13.24 Zesty Paws
13.24.1 Zesty Paws Company Information
13.24.2 Zesty Paws Pet Meds and Supplements Product Portfolios and Specifications
13.24.3 Zesty Paws Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Zesty Paws Main Business Overview
13.24.5 Zesty Paws Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pet Meds and Supplements Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pet Meds and Supplements Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of External Use
Table 4. Major Players of Oral Use
Table 5. Global Pet Meds and Supplements Sales by Type (2018-2023) & (Units)
Table 6. Global Pet Meds and Supplements Sales Market Share by Type (2018-2023)
Table 7. Global Pet Meds and Supplements Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pet Meds and Supplements Revenue Market Share by Type (2018-2023)
Table 9. Global Pet Meds and Supplements Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Pet Meds and Supplements Sales by Application (2018-2023) & (Units)
Table 11. Global Pet Meds and Supplements Sales Market Share by Application (2018-2023)
Table 12. Global Pet Meds and Supplements Revenue by Application (2018-2023)
Table 13. Global Pet Meds and Supplements Revenue Market Share by Application (2018-2023)
Table 14. Global Pet Meds and Supplements Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Pet Meds and Supplements Sales by Company (2018-2023) & (Units)
Table 16. Global Pet Meds and Supplements Sales Market Share by Company (2018-2023)
Table 17. Global Pet Meds and Supplements Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pet Meds and Supplements Revenue Market Share by Company (2018-2023)
Table 19. Global Pet Meds and Supplements Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Pet Meds and Supplements Producing Area Distribution and Sales Area
Table 21. Players Pet Meds and Supplements Products Offered
Table 22. Pet Meds and Supplements Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pet Meds and Supplements Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Pet Meds and Supplements Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pet Meds and Supplements Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pet Meds and Supplements Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pet Meds and Supplements Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Pet Meds and Supplements Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pet Meds and Supplements Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pet Meds and Supplements Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pet Meds and Supplements Sales by Country (2018-2023) & (Units)
Table 34. Americas Pet Meds and Supplements Sales Market Share by Country (2018-2023)
Table 35. Americas Pet Meds and Supplements Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pet Meds and Supplements Revenue Market Share by Country (2018-2023)
Table 37. Americas Pet Meds and Supplements Sales by Type (2018-2023) & (Units)
Table 38. Americas Pet Meds and Supplements Sales by Application (2018-2023) & (Units)
Table 39. APAC Pet Meds and Supplements Sales by Region (2018-2023) & (Units)
Table 40. APAC Pet Meds and Supplements Sales Market Share by Region (2018-2023)
Table 41. APAC Pet Meds and Supplements Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pet Meds and Supplements Revenue Market Share by Region (2018-2023)
Table 43. APAC Pet Meds and Supplements Sales by Type (2018-2023) & (Units)
Table 44. APAC Pet Meds and Supplements Sales by Application (2018-2023) & (Units)
Table 45. Europe Pet Meds and Supplements Sales by Country (2018-2023) & (Units)
Table 46. Europe Pet Meds and Supplements Sales Market Share by Country (2018-2023)
Table 47. Europe Pet Meds and Supplements Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pet Meds and Supplements Revenue Market Share by Country (2018-2023)
Table 49. Europe Pet Meds and Supplements Sales by Type (2018-2023) & (Units)
Table 50. Europe Pet Meds and Supplements Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Pet Meds and Supplements Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Pet Meds and Supplements Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pet Meds and Supplements Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pet Meds and Supplements Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pet Meds and Supplements Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Pet Meds and Supplements Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Pet Meds and Supplements
Table 58. Key Market Challenges & Risks of Pet Meds and Supplements
Table 59. Key Industry Trends of Pet Meds and Supplements
Table 60. Pet Meds and Supplements Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pet Meds and Supplements Distributors List
Table 63. Pet Meds and Supplements Customer List
Table 64. Global Pet Meds and Supplements Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Pet Meds and Supplements Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pet Meds and Supplements Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Pet Meds and Supplements Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pet Meds and Supplements Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Pet Meds and Supplements Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pet Meds and Supplements Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Pet Meds and Supplements Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pet Meds and Supplements Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Pet Meds and Supplements Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pet Meds and Supplements Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Pet Meds and Supplements Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pet Meds and Supplements Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Pet Meds and Supplements Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Boehringer Ingelheim Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 79. Boehringer Ingelheim Pet Meds and Supplements Product Portfolios and Specifications
Table 80. Boehringer Ingelheim Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Boehringer Ingelheim Main Business
Table 82. Boehringer Ingelheim Latest Developments
Table 83. Ceva Sante Animale Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 84. Ceva Sante Animale Pet Meds and Supplements Product Portfolios and Specifications
Table 85. Ceva Sante Animale Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Ceva Sante Animale Main Business
Table 87. Ceva Sante Animale Latest Developments
Table 88. Bimeda Animal Health Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 89. Bimeda Animal Health Pet Meds and Supplements Product Portfolios and Specifications
Table 90. Bimeda Animal Health Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Bimeda Animal Health Main Business
Table 92. Bimeda Animal Health Latest Developments
Table 93. Dechra Pharmaceuticals Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 94. Dechra Pharmaceuticals Pet Meds and Supplements Product Portfolios and Specifications
Table 95. Dechra Pharmaceuticals Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Dechra Pharmaceuticals Main Business
Table 97. Dechra Pharmaceuticals Latest Developments
Table 98. Zoetis Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 99. Zoetis Pet Meds and Supplements Product Portfolios and Specifications
Table 100. Zoetis Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Zoetis Main Business
Table 102. Zoetis Latest Developments
Table 103. Merck Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck Pet Meds and Supplements Product Portfolios and Specifications
Table 105. Merck Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Merck Main Business
Table 107. Merck Latest Developments
Table 108. Elanco Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 109. Elanco Pet Meds and Supplements Product Portfolios and Specifications
Table 110. Elanco Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Elanco Main Business
Table 112. Elanco Latest Developments
Table 113. Bayer Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 114. Bayer Pet Meds and Supplements Product Portfolios and Specifications
Table 115. Bayer Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Bayer Main Business
Table 117. Bayer Latest Developments
Table 118. Boehringer Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 119. Boehringer Pet Meds and Supplements Product Portfolios and Specifications
Table 120. Boehringer Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Boehringer Main Business
Table 122. Boehringer Latest Developments
Table 123. Novartis Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 124. Novartis Pet Meds and Supplements Product Portfolios and Specifications
Table 125. Novartis Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Novartis Main Business
Table 127. Novartis Latest Developments
Table 128. Virbac Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 129. Virbac Pet Meds and Supplements Product Portfolios and Specifications
Table 130. Virbac Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Virbac Main Business
Table 132. Virbac Latest Developments
Table 133. Ceva Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 134. Ceva Pet Meds and Supplements Product Portfolios and Specifications
Table 135. Ceva Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Ceva Main Business
Table 137. Ceva Latest Developments
Table 138. Vetoquinol Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 139. Vetoquinol Pet Meds and Supplements Product Portfolios and Specifications
Table 140. Vetoquinol Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Vetoquinol Main Business
Table 142. Vetoquinol Latest Developments
Table 143. Nexvet Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 144. Nexvet Pet Meds and Supplements Product Portfolios and Specifications
Table 145. Nexvet Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Nexvet Main Business
Table 147. Nexvet Latest Developments
Table 148. Aratana Therapeutics Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 149. Aratana Therapeutics Pet Meds and Supplements Product Portfolios and Specifications
Table 150. Aratana Therapeutics Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Aratana Therapeutics Main Business
Table 152. Aratana Therapeutics Latest Developments
Table 153. Kindred Biosciences Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 154. Kindred Biosciences Pet Meds and Supplements Product Portfolios and Specifications
Table 155. Kindred Biosciences Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Kindred Biosciences Main Business
Table 157. Kindred Biosciences Latest Developments
Table 158. Ambrx Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 159. Ambrx Pet Meds and Supplements Product Portfolios and Specifications
Table 160. Ambrx Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Ambrx Main Business
Table 162. Ambrx Latest Developments
Table 163. Entest Biomedical Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 164. Entest Biomedical Pet Meds and Supplements Product Portfolios and Specifications
Table 165. Entest Biomedical Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Entest Biomedical Main Business
Table 167. Entest Biomedical Latest Developments
Table 168. Taconic Biosciences Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 169. Taconic Biosciences Pet Meds and Supplements Product Portfolios and Specifications
Table 170. Taconic Biosciences Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Taconic Biosciences Main Business
Table 172. Taconic Biosciences Latest Developments
Table 173. Dechra Veterinary Products Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 174. Dechra Veterinary Products Pet Meds and Supplements Product Portfolios and Specifications
Table 175. Dechra Veterinary Products Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Dechra Veterinary Products Main Business
Table 177. Dechra Veterinary Products Latest Developments
Table 178. Ouro Fino Saude Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 179. Ouro Fino Saude Pet Meds and Supplements Product Portfolios and Specifications
Table 180. Ouro Fino Saude Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 181. Ouro Fino Saude Main Business
Table 182. Ouro Fino Saude Latest Developments
Table 183. Norbrook Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 184. Norbrook Pet Meds and Supplements Product Portfolios and Specifications
Table 185. Norbrook Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 186. Norbrook Main Business
Table 187. Norbrook Latest Developments
Table 188. Frontline Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 189. Frontline Pet Meds and Supplements Product Portfolios and Specifications
Table 190. Frontline Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 191. Frontline Main Business
Table 192. Frontline Latest Developments
Table 193. Zesty Paws Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 194. Zesty Paws Pet Meds and Supplements Product Portfolios and Specifications
Table 195. Zesty Paws Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 196. Zesty Paws Main Business
Table 197. Zesty Paws Latest Developments
Table 1. Pet Meds and Supplements Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pet Meds and Supplements Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of External Use
Table 4. Major Players of Oral Use
Table 5. Global Pet Meds and Supplements Sales by Type (2018-2023) & (Units)
Table 6. Global Pet Meds and Supplements Sales Market Share by Type (2018-2023)
Table 7. Global Pet Meds and Supplements Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pet Meds and Supplements Revenue Market Share by Type (2018-2023)
Table 9. Global Pet Meds and Supplements Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Pet Meds and Supplements Sales by Application (2018-2023) & (Units)
Table 11. Global Pet Meds and Supplements Sales Market Share by Application (2018-2023)
Table 12. Global Pet Meds and Supplements Revenue by Application (2018-2023)
Table 13. Global Pet Meds and Supplements Revenue Market Share by Application (2018-2023)
Table 14. Global Pet Meds and Supplements Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Pet Meds and Supplements Sales by Company (2018-2023) & (Units)
Table 16. Global Pet Meds and Supplements Sales Market Share by Company (2018-2023)
Table 17. Global Pet Meds and Supplements Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pet Meds and Supplements Revenue Market Share by Company (2018-2023)
Table 19. Global Pet Meds and Supplements Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Pet Meds and Supplements Producing Area Distribution and Sales Area
Table 21. Players Pet Meds and Supplements Products Offered
Table 22. Pet Meds and Supplements Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pet Meds and Supplements Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Pet Meds and Supplements Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pet Meds and Supplements Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pet Meds and Supplements Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pet Meds and Supplements Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Pet Meds and Supplements Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pet Meds and Supplements Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pet Meds and Supplements Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pet Meds and Supplements Sales by Country (2018-2023) & (Units)
Table 34. Americas Pet Meds and Supplements Sales Market Share by Country (2018-2023)
Table 35. Americas Pet Meds and Supplements Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pet Meds and Supplements Revenue Market Share by Country (2018-2023)
Table 37. Americas Pet Meds and Supplements Sales by Type (2018-2023) & (Units)
Table 38. Americas Pet Meds and Supplements Sales by Application (2018-2023) & (Units)
Table 39. APAC Pet Meds and Supplements Sales by Region (2018-2023) & (Units)
Table 40. APAC Pet Meds and Supplements Sales Market Share by Region (2018-2023)
Table 41. APAC Pet Meds and Supplements Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pet Meds and Supplements Revenue Market Share by Region (2018-2023)
Table 43. APAC Pet Meds and Supplements Sales by Type (2018-2023) & (Units)
Table 44. APAC Pet Meds and Supplements Sales by Application (2018-2023) & (Units)
Table 45. Europe Pet Meds and Supplements Sales by Country (2018-2023) & (Units)
Table 46. Europe Pet Meds and Supplements Sales Market Share by Country (2018-2023)
Table 47. Europe Pet Meds and Supplements Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pet Meds and Supplements Revenue Market Share by Country (2018-2023)
Table 49. Europe Pet Meds and Supplements Sales by Type (2018-2023) & (Units)
Table 50. Europe Pet Meds and Supplements Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Pet Meds and Supplements Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Pet Meds and Supplements Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pet Meds and Supplements Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pet Meds and Supplements Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pet Meds and Supplements Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Pet Meds and Supplements Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Pet Meds and Supplements
Table 58. Key Market Challenges & Risks of Pet Meds and Supplements
Table 59. Key Industry Trends of Pet Meds and Supplements
Table 60. Pet Meds and Supplements Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pet Meds and Supplements Distributors List
Table 63. Pet Meds and Supplements Customer List
Table 64. Global Pet Meds and Supplements Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Pet Meds and Supplements Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pet Meds and Supplements Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Pet Meds and Supplements Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pet Meds and Supplements Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Pet Meds and Supplements Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pet Meds and Supplements Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Pet Meds and Supplements Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pet Meds and Supplements Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Pet Meds and Supplements Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pet Meds and Supplements Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Pet Meds and Supplements Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pet Meds and Supplements Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Pet Meds and Supplements Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Boehringer Ingelheim Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 79. Boehringer Ingelheim Pet Meds and Supplements Product Portfolios and Specifications
Table 80. Boehringer Ingelheim Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Boehringer Ingelheim Main Business
Table 82. Boehringer Ingelheim Latest Developments
Table 83. Ceva Sante Animale Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 84. Ceva Sante Animale Pet Meds and Supplements Product Portfolios and Specifications
Table 85. Ceva Sante Animale Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Ceva Sante Animale Main Business
Table 87. Ceva Sante Animale Latest Developments
Table 88. Bimeda Animal Health Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 89. Bimeda Animal Health Pet Meds and Supplements Product Portfolios and Specifications
Table 90. Bimeda Animal Health Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Bimeda Animal Health Main Business
Table 92. Bimeda Animal Health Latest Developments
Table 93. Dechra Pharmaceuticals Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 94. Dechra Pharmaceuticals Pet Meds and Supplements Product Portfolios and Specifications
Table 95. Dechra Pharmaceuticals Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Dechra Pharmaceuticals Main Business
Table 97. Dechra Pharmaceuticals Latest Developments
Table 98. Zoetis Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 99. Zoetis Pet Meds and Supplements Product Portfolios and Specifications
Table 100. Zoetis Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Zoetis Main Business
Table 102. Zoetis Latest Developments
Table 103. Merck Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck Pet Meds and Supplements Product Portfolios and Specifications
Table 105. Merck Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Merck Main Business
Table 107. Merck Latest Developments
Table 108. Elanco Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 109. Elanco Pet Meds and Supplements Product Portfolios and Specifications
Table 110. Elanco Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Elanco Main Business
Table 112. Elanco Latest Developments
Table 113. Bayer Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 114. Bayer Pet Meds and Supplements Product Portfolios and Specifications
Table 115. Bayer Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Bayer Main Business
Table 117. Bayer Latest Developments
Table 118. Boehringer Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 119. Boehringer Pet Meds and Supplements Product Portfolios and Specifications
Table 120. Boehringer Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Boehringer Main Business
Table 122. Boehringer Latest Developments
Table 123. Novartis Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 124. Novartis Pet Meds and Supplements Product Portfolios and Specifications
Table 125. Novartis Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Novartis Main Business
Table 127. Novartis Latest Developments
Table 128. Virbac Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 129. Virbac Pet Meds and Supplements Product Portfolios and Specifications
Table 130. Virbac Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Virbac Main Business
Table 132. Virbac Latest Developments
Table 133. Ceva Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 134. Ceva Pet Meds and Supplements Product Portfolios and Specifications
Table 135. Ceva Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Ceva Main Business
Table 137. Ceva Latest Developments
Table 138. Vetoquinol Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 139. Vetoquinol Pet Meds and Supplements Product Portfolios and Specifications
Table 140. Vetoquinol Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Vetoquinol Main Business
Table 142. Vetoquinol Latest Developments
Table 143. Nexvet Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 144. Nexvet Pet Meds and Supplements Product Portfolios and Specifications
Table 145. Nexvet Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Nexvet Main Business
Table 147. Nexvet Latest Developments
Table 148. Aratana Therapeutics Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 149. Aratana Therapeutics Pet Meds and Supplements Product Portfolios and Specifications
Table 150. Aratana Therapeutics Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Aratana Therapeutics Main Business
Table 152. Aratana Therapeutics Latest Developments
Table 153. Kindred Biosciences Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 154. Kindred Biosciences Pet Meds and Supplements Product Portfolios and Specifications
Table 155. Kindred Biosciences Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Kindred Biosciences Main Business
Table 157. Kindred Biosciences Latest Developments
Table 158. Ambrx Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 159. Ambrx Pet Meds and Supplements Product Portfolios and Specifications
Table 160. Ambrx Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Ambrx Main Business
Table 162. Ambrx Latest Developments
Table 163. Entest Biomedical Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 164. Entest Biomedical Pet Meds and Supplements Product Portfolios and Specifications
Table 165. Entest Biomedical Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Entest Biomedical Main Business
Table 167. Entest Biomedical Latest Developments
Table 168. Taconic Biosciences Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 169. Taconic Biosciences Pet Meds and Supplements Product Portfolios and Specifications
Table 170. Taconic Biosciences Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Taconic Biosciences Main Business
Table 172. Taconic Biosciences Latest Developments
Table 173. Dechra Veterinary Products Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 174. Dechra Veterinary Products Pet Meds and Supplements Product Portfolios and Specifications
Table 175. Dechra Veterinary Products Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Dechra Veterinary Products Main Business
Table 177. Dechra Veterinary Products Latest Developments
Table 178. Ouro Fino Saude Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 179. Ouro Fino Saude Pet Meds and Supplements Product Portfolios and Specifications
Table 180. Ouro Fino Saude Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 181. Ouro Fino Saude Main Business
Table 182. Ouro Fino Saude Latest Developments
Table 183. Norbrook Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 184. Norbrook Pet Meds and Supplements Product Portfolios and Specifications
Table 185. Norbrook Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 186. Norbrook Main Business
Table 187. Norbrook Latest Developments
Table 188. Frontline Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 189. Frontline Pet Meds and Supplements Product Portfolios and Specifications
Table 190. Frontline Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 191. Frontline Main Business
Table 192. Frontline Latest Developments
Table 193. Zesty Paws Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 194. Zesty Paws Pet Meds and Supplements Product Portfolios and Specifications
Table 195. Zesty Paws Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 196. Zesty Paws Main Business
Table 197. Zesty Paws Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pet Meds and Supplements
Figure 2. Pet Meds and Supplements Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Meds and Supplements Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Pet Meds and Supplements Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pet Meds and Supplements Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of External Use
Figure 10. Product Picture of Oral Use
Figure 11. Global Pet Meds and Supplements Sales Market Share by Type in 2022
Figure 12. Global Pet Meds and Supplements Revenue Market Share by Type (2018-2023)
Figure 13. Pet Meds and Supplements Consumed in Dogs
Figure 14. Global Pet Meds and Supplements Market: Dogs (2018-2023) & (Units)
Figure 15. Pet Meds and Supplements Consumed in Cats
Figure 16. Global Pet Meds and Supplements Market: Cats (2018-2023) & (Units)
Figure 17. Pet Meds and Supplements Consumed in Rabbit
Figure 18. Global Pet Meds and Supplements Market: Rabbit (2018-2023) & (Units)
Figure 19. Pet Meds and Supplements Consumed in Bird
Figure 20. Global Pet Meds and Supplements Market: Bird (2018-2023) & (Units)
Figure 21. Pet Meds and Supplements Consumed in Others
Figure 22. Global Pet Meds and Supplements Market: Others (2018-2023) & (Units)
Figure 23. Global Pet Meds and Supplements Sales Market Share by Application (2022)
Figure 24. Global Pet Meds and Supplements Revenue Market Share by Application in 2022
Figure 25. Pet Meds and Supplements Sales Market by Company in 2022 (Units)
Figure 26. Global Pet Meds and Supplements Sales Market Share by Company in 2022
Figure 27. Pet Meds and Supplements Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Pet Meds and Supplements Revenue Market Share by Company in 2022
Figure 29. Global Pet Meds and Supplements Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Pet Meds and Supplements Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Pet Meds and Supplements Sales 2018-2023 (Units)
Figure 32. Americas Pet Meds and Supplements Revenue 2018-2023 ($ Millions)
Figure 33. APAC Pet Meds and Supplements Sales 2018-2023 (Units)
Figure 34. APAC Pet Meds and Supplements Revenue 2018-2023 ($ Millions)
Figure 35. Europe Pet Meds and Supplements Sales 2018-2023 (Units)
Figure 36. Europe Pet Meds and Supplements Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Pet Meds and Supplements Sales 2018-2023 (Units)
Figure 38. Middle East & Africa Pet Meds and Supplements Revenue 2018-2023 ($ Millions)
Figure 39. Americas Pet Meds and Supplements Sales Market Share by Country in 2022
Figure 40. Americas Pet Meds and Supplements Revenue Market Share by Country in 2022
Figure 41. Americas Pet Meds and Supplements Sales Market Share by Type (2018-2023)
Figure 42. Americas Pet Meds and Supplements Sales Market Share by Application (2018-2023)
Figure 43. United States Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Pet Meds and Supplements Sales Market Share by Region in 2022
Figure 48. APAC Pet Meds and Supplements Revenue Market Share by Regions in 2022
Figure 49. APAC Pet Meds and Supplements Sales Market Share by Type (2018-2023)
Figure 50. APAC Pet Meds and Supplements Sales Market Share by Application (2018-2023)
Figure 51. China Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Pet Meds and Supplements Sales Market Share by Country in 2022
Figure 59. Europe Pet Meds and Supplements Revenue Market Share by Country in 2022
Figure 60. Europe Pet Meds and Supplements Sales Market Share by Type (2018-2023)
Figure 61. Europe Pet Meds and Supplements Sales Market Share by Application (2018-2023)
Figure 62. Germany Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Pet Meds and Supplements Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Pet Meds and Supplements Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Pet Meds and Supplements Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Pet Meds and Supplements Sales Market Share by Application (2018-2023)
Figure 71. Egypt Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Pet Meds and Supplements in 2022
Figure 77. Manufacturing Process Analysis of Pet Meds and Supplements
Figure 78. Industry Chain Structure of Pet Meds and Supplements
Figure 79. Channels of Distribution
Figure 80. Global Pet Meds and Supplements Sales Market Forecast by Region (2024-2029)
Figure 81. Global Pet Meds and Supplements Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Pet Meds and Supplements Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Pet Meds and Supplements Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Pet Meds and Supplements Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Pet Meds and Supplements Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Pet Meds and Supplements
Figure 2. Pet Meds and Supplements Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Meds and Supplements Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Pet Meds and Supplements Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pet Meds and Supplements Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of External Use
Figure 10. Product Picture of Oral Use
Figure 11. Global Pet Meds and Supplements Sales Market Share by Type in 2022
Figure 12. Global Pet Meds and Supplements Revenue Market Share by Type (2018-2023)
Figure 13. Pet Meds and Supplements Consumed in Dogs
Figure 14. Global Pet Meds and Supplements Market: Dogs (2018-2023) & (Units)
Figure 15. Pet Meds and Supplements Consumed in Cats
Figure 16. Global Pet Meds and Supplements Market: Cats (2018-2023) & (Units)
Figure 17. Pet Meds and Supplements Consumed in Rabbit
Figure 18. Global Pet Meds and Supplements Market: Rabbit (2018-2023) & (Units)
Figure 19. Pet Meds and Supplements Consumed in Bird
Figure 20. Global Pet Meds and Supplements Market: Bird (2018-2023) & (Units)
Figure 21. Pet Meds and Supplements Consumed in Others
Figure 22. Global Pet Meds and Supplements Market: Others (2018-2023) & (Units)
Figure 23. Global Pet Meds and Supplements Sales Market Share by Application (2022)
Figure 24. Global Pet Meds and Supplements Revenue Market Share by Application in 2022
Figure 25. Pet Meds and Supplements Sales Market by Company in 2022 (Units)
Figure 26. Global Pet Meds and Supplements Sales Market Share by Company in 2022
Figure 27. Pet Meds and Supplements Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Pet Meds and Supplements Revenue Market Share by Company in 2022
Figure 29. Global Pet Meds and Supplements Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Pet Meds and Supplements Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Pet Meds and Supplements Sales 2018-2023 (Units)
Figure 32. Americas Pet Meds and Supplements Revenue 2018-2023 ($ Millions)
Figure 33. APAC Pet Meds and Supplements Sales 2018-2023 (Units)
Figure 34. APAC Pet Meds and Supplements Revenue 2018-2023 ($ Millions)
Figure 35. Europe Pet Meds and Supplements Sales 2018-2023 (Units)
Figure 36. Europe Pet Meds and Supplements Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Pet Meds and Supplements Sales 2018-2023 (Units)
Figure 38. Middle East & Africa Pet Meds and Supplements Revenue 2018-2023 ($ Millions)
Figure 39. Americas Pet Meds and Supplements Sales Market Share by Country in 2022
Figure 40. Americas Pet Meds and Supplements Revenue Market Share by Country in 2022
Figure 41. Americas Pet Meds and Supplements Sales Market Share by Type (2018-2023)
Figure 42. Americas Pet Meds and Supplements Sales Market Share by Application (2018-2023)
Figure 43. United States Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Pet Meds and Supplements Sales Market Share by Region in 2022
Figure 48. APAC Pet Meds and Supplements Revenue Market Share by Regions in 2022
Figure 49. APAC Pet Meds and Supplements Sales Market Share by Type (2018-2023)
Figure 50. APAC Pet Meds and Supplements Sales Market Share by Application (2018-2023)
Figure 51. China Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Pet Meds and Supplements Sales Market Share by Country in 2022
Figure 59. Europe Pet Meds and Supplements Revenue Market Share by Country in 2022
Figure 60. Europe Pet Meds and Supplements Sales Market Share by Type (2018-2023)
Figure 61. Europe Pet Meds and Supplements Sales Market Share by Application (2018-2023)
Figure 62. Germany Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Pet Meds and Supplements Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Pet Meds and Supplements Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Pet Meds and Supplements Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Pet Meds and Supplements Sales Market Share by Application (2018-2023)
Figure 71. Egypt Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Pet Meds and Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Pet Meds and Supplements in 2022
Figure 77. Manufacturing Process Analysis of Pet Meds and Supplements
Figure 78. Industry Chain Structure of Pet Meds and Supplements
Figure 79. Channels of Distribution
Figure 80. Global Pet Meds and Supplements Sales Market Forecast by Region (2024-2029)
Figure 81. Global Pet Meds and Supplements Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Pet Meds and Supplements Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Pet Meds and Supplements Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Pet Meds and Supplements Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Pet Meds and Supplements Revenue Market Share Forecast by Application (2024-2029)
